Initially developed to improve glycemic control in type 2 diabetes mellitus (T2DM), these agents have demonstrated additional benefits such as weight loss, blood pressure reduction, and importantly, cardiovascular and renal protection
But they arguably wouldn't be here if it wasn't for Eng's work which created the very first GLP-1 drug
Tirzepatide has shown greater efficacy than semaglutide due to its dual action on glucagon-like peptide-1 and glucose-dependent insulinotropic peptide receptors
Participants receive regular clinical assessments, laboratory monitoring (including liver function, renal function, lipase levels, and thyroid function where indicated), and structured follow-up
Depending on what your doctor says, you may continue at 0.5 milligrams as your weekly dosage
to docket no